What is the difference between cell and gene therapy?

Gene therapy is the transfer of genetic material, often in the form of a vector or carrier, and the absorption of the gene into the relevant body cells. Cells with the appropriate function are transferred into the patient during cell therapy.

What is CAR T-cell therapy?

With CAR T treatment, cancer cells are targeted by genetically altered T cells from the patients own immune system or those of a donor.

What are the references?

Centers for Disease Control and Prevention, American Heart Association, National Institute of Environmental Health Sciences, National Cancer Institute, and American Society of Gene & Cell Therapy.

U.S. Cell Therapy Market Skyrockets by 21.46% CAGR till 2034

Content

Introduction Research Methodology Executive Summary Market Dynamics Market Overview U.S. Cell Therapy Market Assessment Cross Segments Analysis Integration of AI in U.S. Cell Therapy Market Production and Consumption Analysis Opportunity Assessment Company Profiles Regulatory and Policy Framework Emerging Trends Appendices

Introduction

Research Objective
Scope of the Study
Definition and Taxonomy

Research Methodology

Research Approach
Data Sources
Assumptions

Executive Summary

Synopsis
Analyst Recommendations

Market Dynamics

Trends and Drivers
Challenges and Barriers

Market Overview

Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
Value Chain Analysis
- Raw Material Sourcing
- Manufacturing Process
- Logistics & Transportation
- Buyer Preferences
Trends
- Market Trends
- Technological Trends
Porter’s Five Forces Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitute
- Threat of New Entrants
- Degree of Competition
PESTLE Analysis for 5 Leading Countries
- Regulatory Framework for Leading Countries/Regions
- Supply Demand Analysis
- Production & Consumption Statistics
- Export Import Statistics
- Price Trend Analysis

U.S. Cell Therapy Market Assessment

Overview
U.S. Cell Therapy Market Size Value (US$) and Volume (Billion Tons), by Therapy Type (2021 – 2033)
- Allogeneic Therapies
  - Stem Cell Therapies
    - Hematopoietic Stem Cell Therapies
    - Mesenchymal Stem Cell Therapies
  - Non-Stem Cell Therapies
    - Keratinocytes & Fibroblast-based Therapies
    - Others
- Autologous Therapies
  - T-Cell Therapies
    - CAR T Cell Therapy
    - T Cell Receptor (TCR)-based
  - Others
U.S. Cell Therapy Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Area (2021 – 2033)
- Oncology
- Dermatology
- Others

Cross Segments Analysis

By Therapy Type

Allogeneic Therapies
- Overview
- Oncology
- Dermatology
- Others
Stem Cell Therapies
- Hematopoietic Stem Cell Therapies
  - Overview
  - Oncology
  - Dermatology
  - Others
- Mesenchymal Stem Cell Therapies
  - Overview
  - Oncology
  - Dermatology
  - Others
Non-Stem Cell Therapies
- Keratinocytes & Fibroblast-based Therapies
  - Overview
  - Oncology
  - Dermatology
  - Others
- Others
  - Overview
  - Therapeutic Applications
Autologous Therapies
- T-Cell Therapies
  - CAR T Cell Therapy
    - Overview
    - Oncology
    - Dermatology
    - Others
  - T Cell Receptor (TCR)-based
    - Overview
    - Oncology
    - Dermatology
    - Others
- Others
  - Overview
  - Therapeutic Applications

By Therapeutic Area

Oncology
- Allogeneic Therapies
  - Overview
  - Specific Applications
- Stem Cell Therapies
  - Hematopoietic Stem Cell Therapies
    - Overview
    - Specific Applications
  - Mesenchymal Stem Cell Therapies
    - Overview
    - Specific Applications
- Non-Stem Cell Therapies
  - Keratinocytes & Fibroblast-based Therapies
    - Overview
    - Specific Applications
  - Others
    - Overview
    - Specific Applications
- Autologous Therapies
  - T-Cell Therapies
    - CAR T Cell Therapy
      - Overview
      - Specific Applications
    - T Cell Receptor (TCR)-based
      - Overview
      - Specific Applications
  - Others
    - Overview
    - Specific Applications
Dermatology
- Allogeneic Therapies
  - Overview
  - Specific Applications
- Stem Cell Therapies
  - Hematopoietic Stem Cell Therapies
    - Overview
    - Specific Applications
  - Mesenchymal Stem Cell Therapies
    - Overview
    - Specific Applications
- Non-Stem Cell Therapies
  - Keratinocytes & Fibroblast-based Therapies
    - Overview
    - Specific Applications
  - Others
    - Overview
    - Specific Applications
- Autologous Therapies
  - T-Cell Therapies
    - CAR T Cell Therapy
      - Overview
      - Specific Applications
    - T Cell Receptor (TCR)-based
      - Overview
      - Specific Applications
  - Others
    - Overview
    - Specific Applications
Others
- Allogeneic Therapies
  - Overview
  - Specific Applications
- Stem Cell Therapies
  - Hematopoietic Stem Cell Therapies
    - Overview
    - Specific Applications
  - Mesenchymal Stem Cell Therapies
    - Overview
    - Specific Applications
- Non-Stem Cell Therapies
  - Keratinocytes & Fibroblast-based Therapies
    - Overview
    - Specific Applications
  - Others
    - Overview
    - Specific Applications
- Autologous Therapies
  - T-Cell Therapies
    - CAR T Cell Therapy
      - Overview
      - Specific Applications
    - T Cell Receptor (TCR)-based
      - Overview
      - Specific Applications
  - Others
    - Overview
    - Specific Applications

Integration of AI in U.S. Cell Therapy Market

Introduction to AI in Cell Therapy
- Overview of AI Technologies
- Role of AI in Cell Therapy
AI Applications in Cell Therapy
- Data Analysis and Interpretation
  - Predictive Analytics
  - Pattern Recognition
- Treatment Personalization
  - Patient-Specific Treatment Plans
  - Adaptive Therapy Models
- Drug Discovery and Development
  - Identifying Potential Therapeutic Targets
  - Accelerating Preclinical Studies
- Clinical Trials Optimization
  - Patient Recruitment and Retention
  - Trial Design and Monitoring
AI in Cell Therapy Manufacturing
- Process Automation
  - Automation of Production Processes
  - Quality Control and Assurance
- Supply Chain Management
  - Inventory Management
  - Logistics Optimization
AI-Driven Diagnostics
- Disease Detection and Prognosis
  - Early Detection of Target Diseases
  - Prognostic Models for Disease Progression
- Biomarker Discovery
  - Identifying and Validating Biomarkers
AI and Regulatory Compliance
- Regulatory Guidelines for AI Integration
  - FDA Guidelines and Approvals
  - Ethical Considerations
- Data Privacy and Security
  - Ensuring Patient Data Protection
  - Compliance with HIPAA and Other Regulations
Case Studies
- Successful AI Implementations
  - Examples from Leading Companies
  - Impact on Treatment Outcomes
- Lessons Learned and Challenges
  - Challenges Faced During AI Integration
  - Strategies for Overcoming Barriers
Future Trends and Innovations
- Emerging AI Technologies
  - Advances in Machine Learning and Deep Learning
  - Future Applications in Cell Therapy
- Impact on Market Dynamics
  - Market Opportunities and Threats
  - Potential for Disruption

Production and Consumption Analysis

Introduction
- Overview of Production and Consumption Data
Production Data
- Production Overview
- Production by Therapy Type
  - Allogeneic Therapies
  - Stem Cell Therapies
    - Hematopoietic Stem Cell Therapies
    - Mesenchymal Stem Cell Therapies
  - Non-Stem Cell Therapies
    - Keratinocytes & Fibroblast-based Therapies
    - Others
  - Autologous Therapies
    - T-Cell Therapies
      - CAR T Cell Therapy
      - T Cell Receptor (TCR)-based
    - Others
- Production by Therapeutic Area
  - Oncology
  - Dermatology
  - Others
Consumption Data
- Consumption Overview
- Consumption by Therapy Type
  - Allogeneic Therapies
  - Stem Cell Therapies
    - Hematopoietic Stem Cell Therapies
    - Mesenchymal Stem Cell Therapies
  - Non-Stem Cell Therapies
    - Keratinocytes & Fibroblast-based Therapies
    - Others
  - Autologous Therapies
    - T-Cell Therapies
      - CAR T Cell Therapy
      - T Cell Receptor (TCR)-based
    - Others
- Consumption by Therapeutic Area
  - Oncology
  - Dermatology
  - Others
Analysis and Insights
- Trends in Production and Consumption
- Key Drivers and Challenges

Opportunity Assessment

New Product Development
- Emerging Trends in Cell Therapy
- Innovation in Therapy Types
- Case Studies of Recent Product Launches
Plan Finances/ROI Analysis
- Financial Projections and Budgets
- Return on Investment (ROI) Metrics
- Cost-Benefit Analysis of Cell Therapy Investments
Supply Chain Intelligence/Streamline Operations
- Overview of Supply Chain for Cell Therapies
- Strategies for Optimizing Supply Chain Efficiency
- Risk Management in Supply Chain
Cross-Border Intelligence
- Market Opportunities in International Markets
- Regulatory Considerations for Cross-Border Operations
- Partnership and Collaboration Opportunities Abroad
Business Model Innovation
- Emerging Business Models in Cell Therapy
- Case Studies of Successful Business Model Adaptations
- Strategic Recommendations for Business Model Enhancement
Blue Ocean vs. Red Ocean Strategies
- Analysis of Blue Ocean Strategies in Cell Therapy
- Competitive Landscape and Red Ocean Strategies
- Strategic Recommendations for Differentiation and Market Expansion

Company Profiles

Aurion Biotech
- Company Overview
- Geographic Footprints
- Financial Performance
- Product Portfolio
- SWOT Analysis
- R&D Efforts
- Recent Developments & Strategic Collaborations
  - Product Launch/M&A/Technical Collaboration
Vertex Pharmaceuticals Incorporated
Cellular Biomedicine Group, Inc
Nkarta, Inc
Atara Biotherapeutics, Inc
Johnson & Johnson
CARGO Therapeutics, Inc.
Bristol-Myers Squibb Company
Selecta Bioscience
Gilead Sciences, Inc.

Regulatory and Policy Framework

Overview of Regulatory Environment
- U.S. Regulatory Agencies
- Regulatory Pathways for Cell Therapies
- Compliance and Standards
Policy Impacts
- Healthcare Policy and Reimbursement
- Legislation Affecting Cell Therapy
- Ethical and Legal Considerations
Future Outlook and Opportunities
- Anticipated Regulatory Changes
- Opportunities for Policy Advocacy
- Impact on Market Dynamics

Emerging Trends

Technological Innovations
- Advancements in Cell Therapy Technologies
- Integration with Digital Health
Market Developments
- New Product Introductions
- Investment and Funding Trends
Consumer and Patient Trends
- Changing Patient Preferences
  - Trends in Patient Expectations and Demand
- Adoption Rates and Market Penetration

Appendices

Definitions and Terminology
References

Insight Code: 5159
No. of Pages: 150+
Format: PDF/PPT/Excel
Published: May 2025
Report Covered: [Revenue + Volume]
Historical Year: 2021-2022
Base Year: 2023
Estimated Years: 2024-2033